zardaverine has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
zardaverine: structure given in first source
zardaverine : A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kodimuthali, A | 1 |
| Jabaris, SS | 1 |
| Pal, M | 1 |
| Rickards, KJ | 1 |
| Page, CP | 1 |
| Lees, P | 1 |
| Cunningham, FM | 1 |
1 review available for zardaverine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
Topics: Asthma; Humans; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chr | 2008 |
1 other study available for zardaverine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Phosphodiesterase activity in neutrophils from horses with chronic obstructive pulmonary disease.
Topics: Animals; Dose-Response Relationship, Immunologic; Guanidines; Horse Diseases; Horses; Isoenzymes; Ne | 2000 |